These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 35318117)

  • 1. Lift the curtain on long non-coding RNAs in hematological malignancies: Pathogenic elements and potential targets.
    Iannello A; Ciarrocchi A; Fragliasso V; Vaisitti T
    Cancer Lett; 2022 Jun; 536():215645. PubMed ID: 35318117
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Review: Regulation of the cancer epigenome by long non-coding RNAs.
    Forrest ME; Khalil AM
    Cancer Lett; 2017 Oct; 407():106-112. PubMed ID: 28400335
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long non-coding RNAs in hematological malignancies: translating basic techniques into diagnostic and therapeutic strategies.
    Wong NK; Huang CL; Islam R; Yip SP
    J Hematol Oncol; 2018 Nov; 11(1):131. PubMed ID: 30466456
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Behind the curtain of non-coding RNAs; long non-coding RNAs regulating hepatocarcinogenesis.
    El Khodiry A; Afify M; El Tayebi HM
    World J Gastroenterol; 2018 Feb; 24(5):549-572. PubMed ID: 29434445
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long non-coding RNAs (lncRNAs) signaling in cancer chemoresistance: From prediction to druggability.
    Eptaminitaki GC; Stellas D; Bonavida B; Baritaki S
    Drug Resist Updat; 2022 Dec; 65():100866. PubMed ID: 36198236
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long antisense non-coding RNAs and the epigenetic regulation of gene expression.
    Vadaie N; Morris KV
    Biomol Concepts; 2013 Aug; 4(4):411-5. PubMed ID: 25436590
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long non-coding RNAs as an epigenetic regulator in human cancers.
    Kondo Y; Shinjo K; Katsushima K
    Cancer Sci; 2017 Oct; 108(10):1927-1933. PubMed ID: 28776911
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of non-coding RNAs in hematological malignancies.
    Ghafouri-Fard S; Esmaeili M; Taheri M
    Eur J Pharmacol; 2020 May; 875():172976. PubMed ID: 32112777
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interplay between long non-coding RNAs and epigenetic machinery: emerging targets in cancer?
    Hanly DJ; Esteller M; Berdasco M
    Philos Trans R Soc Lond B Biol Sci; 2018 Jun; 373(1748):. PubMed ID: 29685978
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Drug-induced modifications and modulations of microRNAs and long non-coding RNAs for future therapy against Glioblastoma Multiforme.
    Janaki Ramaiah M; Divyapriya K; Kartik Kumar S; Rajesh YBRD
    Gene; 2020 Jan; 723():144126. PubMed ID: 31589963
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Advances in esophageal cancer: A new perspective on pathogenesis associated with long non-coding RNAs.
    Huang X; Zhou X; Hu Q; Sun B; Deng M; Qi X; Lü M
    Cancer Lett; 2018 Jan; 413():94-101. PubMed ID: 29104147
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long non-coding RNAs: implications in targeted diagnoses, prognosis, and improved therapeutic strategies in human non- and triple-negative breast cancer.
    Rodríguez Bautista R; Ortega Gómez A; Hidalgo Miranda A; Zentella Dehesa A; Villarreal-Garza C; Ávila-Moreno F; Arrieta O
    Clin Epigenetics; 2018; 10():88. PubMed ID: 29983835
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulatory mechanisms of long noncoding RNAs on gene expression in cancers.
    Sun W; Yang Y; Xu C; Guo J
    Cancer Genet; 2017 Oct; 216-217():105-110. PubMed ID: 29025584
    [TBL] [Abstract][Full Text] [Related]  

  • 14. LncRNAs: the good, the bad, and the unknown.
    Arunkumar G
    Biochem Cell Biol; 2024 Feb; 102(1):9-27. PubMed ID: 37579511
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long Non-Coding RNAs As Epigenetic Regulators in Cancer.
    Vafadar A; Shabaninejad Z; Movahedpour A; Mohammadi S; Fathullahzadeh S; Mirzaei HR; Namdar A; Savardashtaki A; Mirzaei H
    Curr Pharm Des; 2019; 25(33):3563-3577. PubMed ID: 31470781
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long noncoding RNAs in hematopoietic malignancies.
    Rodríguez-Malavé NI; Rao DS
    Brief Funct Genomics; 2016 May; 15(3):227-38. PubMed ID: 26612601
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long non-coding RNAs and their implications in cancer epigenetics.
    Beckedorff FC; Amaral MS; Deocesano-Pereira C; Verjovski-Almeida S
    Biosci Rep; 2013 Aug; 33(4):. PubMed ID: 23875687
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long noncoding RNAs: emerging regulators of normal and malignant hematopoiesis.
    Qiu Y; Xu M; Huang S
    Blood; 2021 Dec; 138(23):2327-2336. PubMed ID: 34482397
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The contributory role of long non-coding RNAs (lncRNAs) in head and neck cancers: Possible biomarkers and therapeutic targets?
    Akbari Dilmaghani N; Khoshsirat S; Shanaki-Bavarsad M; Pourbagheri-Sigaroodi A; Bashash D
    Eur J Pharmacol; 2021 Jun; 900():174053. PubMed ID: 33766619
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Exploiting Long Noncoding RNAs as Pharmacological Targets to Modulate Epigenetic Diseases.
    Prabhakar B; Zhong XB; Rasmussen TP
    Yale J Biol Med; 2017 Mar; 90(1):73-86. PubMed ID: 28356895
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.